key: cord-0990827-ntg4ikyz
authors: Pauli, Monique Abreu; Pereira, Luanna de Melo; Monteiro, Maria Luiza; de Camargo, Alessandra Rodrigues; Rabelo, Gustavo Davi
title: Painful palatal lesion in a COVID-19 patient
date: 2021-03-28
journal: Oral Surg Oral Med Oral Pathol Oral Radiol
DOI: 10.1016/j.oooo.2021.03.010
sha: aa8a89e0f17de46404b5a2686baea6b6e12a9f38
doc_id: 990827
cord_uid: ntg4ikyz

nan

by mild pain symptoms in the area of the lesion. However, on day 7, the pain became more severe and irradiated across the entire palate and middle third of the face. Examination of the clinical photographs revealed a deep ulcerated lesion located at the center of the hard palate (over the midline). The bone was exposed, and the lesion measured around 2 cm at the widest diameter. The lesion was surrounded by an erythematous halo, the borders appeared lobulated, and focal areas were swollen ( Figure 1 ).

Among several reactive and inflammatory conditions, necrotizing sialometaplasia (NSM)

is known to present initially as an ulcer in the palate. This destructive inflammatory benign disease locally affects the salivary glands. People with NSM can feel pain or be asymptomatic, so it might be clinically and pathologically difficult to distinguish NSM from certain malignancies 1 . Although NSM usually appears on the palate, there are reports of this condition in other intraoral sites, such as the retromolar area, labial mucosa, tongue, floor of the mouth, and buccal mucosa 1 . In our case, NSM was first considered because the patient reported the lesion started with a wound that did not heal. NSM frequently affects the palatal minor salivary glands, which might be related to the use of removable partial denture. Even though the patient did not report whether the denture was ill-fitted and whether its use was interrupted in the first approach, one could assume that the prosthetic appliance could be related to the lesion. Moreover, it is unknown whether the rapid progression of the lesion and worsening of its appearance could be related to COVID-19 disease, as an exacerbation of the symptoms could occur mostly because of the inflammatory systemic condition Besides NSM, other inflammatory conditions were not considered for differential diagnosis, mostly because of the rapid progression of the lesion and bone exposure after seven days.

Malignant lesions were implied in the differential diagnosis in this case. Salivary gland tumors were considered because the lesion was located in the palate. These tumors are uncommon and account for 3-5% of all neoplasms in the head and neck region. A systematic review by Galdirs et al. (2019) showed that the majority of tumors in the minor salivary glands were malignant 2 . In this present case, the lesion's location in the hard palate was the only feature favoring the hypothesis of a malignant salivary gland neoplasm. Another aspect was observed: the borders of the lesion were raised and rolled-appearing, suggesting an indurated (i.e., firm, hard) process and some neoplastic lesions could ulcerate as they progress. However, the rapid evolution and the absence of a mass (as seen in the pictures)

were crucial to consider neoplasm as a less probable option in the differential diagnosis.

Because of the impossibility to perform imaging exams at that time due to the isolation of the patient, clinical presentation was the only source of information for diagnosis. Other hypothesis of malignant lesion for the present case was the possibility of a lymphoma.

Lymphomas in the oral cavity account for 3% of all malignant tumors of the head and neck, and they clinically present as a mass, with ulceration and with or without superficial necrosis 3 . Regarding this information and clinical presentation, this hypothesis was included in the diagnosis list, considering that the palate is the most common intraoral location for extranodal malignant lymphomas.

Infectious diseases were the most emphasized group of lesions for differential diagnosis. Fungal diseases along with lesions in the oral cavity commonly occur in some concluded that the clinical presentation of oral leishmaniasis (OL) is unusual, which underlies the importance to consider leishmaniasis in the differential diagnosis of oral lesions, especially in endemic areas 5 . According to a review study, the incidence of mucormycosis in South America is increasing: it appeared in 41% of the 143 Brazilian patients. The mean age of the patients was 40.0 years (43.0 in Brazil, 37.5 in the other countries of South America) 6 .

In the case reported here, both clinical condition and prevalence rates were considered for inclusion of fungal and parasite diseases in the differential diagnosis.

Because of bone exposure in this case, bone infections were also considered. At this point, we needed more information from the patient to include or not bone necrosis in the diagnosis. Medication-related osteonecrosis of the jaws (MRONJ) is a bone necrosis induced by antiangiogenic and/or antiresorptive drugs, such as bisphosphonates, bevacizumab, and denosumab. The most common clinical presentation includes exposure of bone surfaces in the maxilla, local pain, sequestrum formation and secondary local infection 7 . To distinguish the lesion from other delayed healing conditions, we reviewed the patient's medical history to discard the possibility of previous use of bisphosphonates, bevacizumab, and denosumab. On a second call consultation, which was guided by a structured questionnaire, the patient reinforced the information that she was not on antiresorptive treatment; thus, the hypothesis of MRONJ was rejected. Osteomyelitis was also considered. Osteomyelitis is an inflammatory, usually infectious bone marrow condition with a wide range of clinical presentations; it arises more often in the mandible than the maxilla. Some of the osteomyelitis symptoms are pain, edema, fever, adynamia, and cutaneous fistula 8 . We included osteomyelitis in the differential diagnosis because of the acute evolution of the lesion and because the patient had COVID-19 and diabetes; little is known about the evolution of these diseases in comorbidity, as both could be worsened by a bacterial infection progression.

The main challenge was to include COVID-19-related lesions in the diagnosis process for this case. There is scarce information on oral findings for this condition, and the literature reported that oral mucosal lesions are more likely to present as co-infections or secondary manifestations with multiple clinical aspects 10 . In this specific case, COVID-19 oral manifestations were included in the spectrum of possible diagnosis, although co-infection was likely to be considered. The patient reported mild symptoms of COVID-19 disease (i.e., no fever, only headache and some discomfort), and interestingly, no complaints of taste loss.

Until the end of the mandatory isolation period, the patient was prescribed antibiotics (amoxicillin with potassium clavulanate for 7 days) along with a non-steroidal antiinflammatory drug and tramadol (centrally acting analgesic) due to the intense pain.

Antiseptic mouthwashes were also indicated three times a day. During isolation, the patient reported one episode in which she received intravenous medication in an emergency medical service for controlling the pain. After this period, the patient attended the dental office for intraoral examination. Imaging exams were requested, and an incisional biopsy was performed under local anesthesia. Next, the patient underwent a cone beam computed tomography scan. Tomographic images revealed a maxilla with normal contour, without signs of significant eroded areas. She was advised to seek a consultation with a physician to check her diabetes status. A fasting blood sugar test revealed a glucose level of 218 mg/dL.

The patient signed a written informed consent form for the present study.

Histological examination of the biopsy showed an ulcerated lesion with coagulative necrosis, hemorrhage and abundant neutrophils. In the necrotic material, especially in blood vessels walls, there were many large non-septate hyphae with thin walls and branches at 90 degrees, which were well visualized with hematoxylin and eosin staining (Figure 2 ). These hyphae were evidenced with Grocott's methenamine ( Figure 2 ) and special stains for fungilike periodic acid-Schiff (PAS) (Figure 2 ). The morphological diagnosis of mucormycosis was confirmed. A high-resolution version of the examined slides is available as eSlides VM06234, VM06235, and VM 06236 for assessment via Virtual Microscope.

After the diagnosis of mucormycosis, the patient was quickly referred for hospitalization to start treatment. At the hospital, a series of tests was carried out to identify whether the disease had compromised the lungs and other organs. Imaging exams revealed no other affected sites. The patient started the treatment with intravenous (IV) amphotericin B in association with hydrocortisone. After 10 days of IV medication, superficial debridement of the lesion was conducted. In addition, the patient presented a respiratory allergic reaction, so an antihistamine therapy was introduced. Diabetes mellitus was also controlled during hospitalization. After approximately one month and a half of hospitalization, the patient was sent home with no pain or any other symptoms. The patient attended the dental office for clinical evaluation of the hard palate, which seemed recovered 10 days after discharge from the hospital.

Mucormycosis is a rare and potentially lethal invasive fungal infection caused by saprophytic aerobic fungi Rhizopus, Rhizomucor and Cunninghamella genera of the family Mucoraceae, which colonize the oral and nasal mucosa and paranasal sinuses 11 . The disease usually evolves rapidly in immunocompromised or debilitated patients, that is, those with uncontrolled diabetes, uncontrolled HIV infection, malignant hematological diseases, and solid organ transplantation. This disease rarely affects patients with no underlying condition 12 . The epidemiology of mucormycosis is difficult to be determined, mostly because of its rarity 13 . However, due to the increasing number of immunocompromised patients, aging of the population and better health care with higher overall survival rates, there has been an increase in the incidence of this disease in the last decades 12 .

Disease transmission seems to occur mainly via inhalation of spores from environmental sources 13 . Mucormycosis usually presents a worse outcome compared to other invasive fungal infections. The most common clinical presentation of mucormycosis is sinusitis (rhinocerebral infection), followed by pulmonary, cutaneous/subcutaneous and disseminated diseases 13 . Tissue necrosis is the hallmark of mucormycosis, resulting from angioinvasion and subsequent vascular thrombosis 13, 14 . Oral manifestations of mucormycosis usually include bone exposure and necrosis, which demands histopathological examination to confirm the diagnosis due to its non-specificity features and possible similarities to bacterial osteomyelitis, trauma and iatrogenic infections 14 .

Oral mucormycosis without any other systemically compromised organs is quite uncommon. In our case, the patient had both a debilitating condition resulting from poorly controlled diabetes and acute inflammatory immune response due to COVID-19. Other case reports of oral manifestations related to mucormycosis identified triggering or predisposing factors for local and systemic conditions. Rajashri, Muthusekhar & Santhosh (2020) reported oral mucormycosis in a diabetic patient after tooth extraction 14 Co-infections in COVID-19 patients are an emerging concern, especially because of their complex diagnosis, severity, and increased mortality 20 were identified with AVN 24 . Those authors believe that administration of corticosteroids (which is frequently prescribed to severely ill patients) in SARS patients could be the major predisposing factor for AVN development, recommending that steroids should be administrated cautiously. Considering that the disease can be severe in COVID-19 patients, it is important to know the possible effects of the medicines being prescribed to these patients to avoid major systemic complications.

Early diagnosis is the best way to manage oral mucormycosis, along with reversal of the underlying predisposing risk factors and systemic disorders, surgical debridement and prompt administration of active antifungal agents 16 . Because COVID-19 patients may need quarantine and social isolation, tele-healthcare and/or tele-dentistry can be the best way to provide early diagnosis. Initial evaluation of pictures and clinical images is crucial to start the diagnosis process. In our case, the pictures of the patient along with her medical history and major complaints allowed us to recognize her oral condition and conduct the differential diagnosis process. Martins et al. (2020) reported that literature evidence supports the use of tele-consultation and tele-education as effective alternatives in this period of pandemics to avoid the spread of SARS-CoV-2 and its collateral damage. The authors also emphasize that dental care delivery needs to be redesigned 25 .

To the best of our knowledge, this is the first case report of a COVID-19 patient with oral mucormycosis. Mucormycosis disease, along with other deep fungal infections, should be considered as an important outcome of Sars-CoV-2 infection. As COVID-19 is still under investigation, all possible associations with the disease should be reported. In addition, the possibility to obtain information from non-in-person consultation could be an alternative for patients in quarantine.

The authors declare that they have no conflicts of interest. No potential competing interest was declared by the authors. The lesion appears to be resolving and the patient is asymptomatic. 

Review of the literature on necrotizing sialometaplasia and case presentation

Current aspects of salivary gland tumors -a systematic review of the literature

Immunophenotyping for Diagnosis of Oral Lesions: Is It an Important Tool?

Oral Paracoccidioidomycosis affecting Women: a Systematic Review

Exclusive Primary Lesion of Oral Leishmaniasis with Immunohistochemical Diagnosis

Mucormycosis in South America: A review of 143 reported cases

Bisphosphonate-related osteonecrosis of the jaws and its array of manifestations

Recommendations for the treatment of osteomyelitis

Oral lesions in patients with SARS-CoV-2 infection: could the oral cavity be a target organ? Oral Surg Oral Med Oral Pathol Oral Radiol

Oral Manifestations in Patients with COVID-19: A Living Systematic Review

Mucormycotic osteomyelitis of maxilla following maxillofacial trauma: The disease of the diseased

Epidemiology and outcome of zygomycosis: A review of 929 reported cases

Challenges in the diagnosis and treatment of mucormycosis

Mucormycosis Following Tooth Extraction in a Diabetic Patient: A Case Report

Invasive Oral Tongue Mucormycosis Rapidly Presenting After Orthotopic Liver Transplant

Oral mucormycosis and aspergillosis in the patient with acute leukemia

Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. The Lancet Microbe

Mucormycosis with orbital compartment syndrome in a patient with COVID-19

Fungal Co-infections Associated with Global COVID-19 Pandemic: A Clinical and Diagnostic Perspective from China

Co-infections: potentially lethal and unexplored in COVID-19. The Lancet Microbe

Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing

Necrotizing periodontal disease: Oral manifestation of COVID-19

Skin and mucosal damage in patients diagnosed with CoviD-19 a case report

Avascular necrosis of bone in severe acute respiratory syndrome